Google Übersetzer
About
Therasense Inc (PINK:THER) — investor relations, events, news, and company updates on 6ix.
Latest News
Sep 27 2018
OncBioMune Initiates Phase 2 Clinical Trial of Novel Vaccine as Front-Line Treatment for Prostate Cancer
Jul 9 2018
OncBioMune’s Phase 2 Clinical Trial of ProscaVax for Early-Stage Prostate Cancer is Now Included on ClinicalTrials.gov
Jul 2 2018
OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer
Jun 20 2018
OncBioMune to Commence Phase 2 Trial of ProscaVax for Early Stage Prostate Cancer Patients
Jun 6 2018
OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of May
Recent Videos
Therasense, Inc. v. Becton-Dickinson, Inc. Case Brief Summary | Law Case Explained
Jul 29, 2021
The Ethical Ramifications of Therasense
Sep 30, 2013
Financials
Revenue
$635.45 K
Market Cap
$615.15 K
EPS
0.00